FDA Inspection
Inopak LtdInopak Ltd – FDA Inspection, Jul 20, 2018
Record Details
This FDA Inspection record concerns Inopak Ltd, with an inspection on July 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Guerlain Ulysse (FDA Associated Person)
- Yvesna C. Blaise (Issuing Officer)
View Company Profile
ID · c0307baa-4e31-4b91-871b-468b8719c9fe
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1059942
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of Inopak Ltd
6| Date | Classification | Office | Project area |
|---|---|---|---|
| August 3, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Inopak Ltd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.